<?xml version="1.0" encoding="UTF-8"?>
<p id="p0295">When available, viral genomes modified with reporter genes can be used for cell-based luminescent or fluorescent screening of viral inhibitors (
 <xref rid="bb0110" ref-type="bibr">Beadle et al., 2016</xref>, 
 <xref rid="bb0455" ref-type="bibr">Edwards et al., 2015</xref>, 
 <xref rid="bb0495" ref-type="bibr">Fenaux et al., 2016</xref>, 
 <xref rid="bb0505" ref-type="bibr">Feng et al., 2014</xref>, 
 <xref rid="bb1090" ref-type="bibr">Lo et al., 2017</xref>, 
 <xref rid="bb1140" ref-type="bibr">Madhvi et al., 2017</xref>, 
 <xref rid="bb1785" ref-type="bibr">Wang et al., 2015c</xref>). This approach can be extended to screen inhibitors of other enzymes. In the aptamer-based approach, a DNA template encodes RNA of interest joined to a fluorescence module and ribozyme sequence. When transcribed, the fluorescence module is released and detected (
 <xref rid="bb0745" ref-type="bibr">HÃ¶fer et al., 2013</xref>).
</p>
